Hrev_master Veins and Lymphatics 2013; volume 2:e21 [page 76] [Veins and Lymphatics 2013; 2:e21] Short endovenous laser ablation of the great saphenous vein in a modified CHIVA strategy Sergio Gianesini, Erica Menegatti, Michele Zuolo, Mirko Tessari, Simona Ascanelli, Savino Occhionorelli, Paolo Zamboni Vascular Disease Center, University of Ferrara, Italy Abstract Mini-invasiveness, ease of use and execu- tion speed represent the reasons for endove- nous laser ablation success. Nevertheless, the strategic choice remains the ablation of the saphenous trunk. Hemodynamic correction (CHIVA) represents an option, based on a saphenous-sparing therapeutic strategy. We tested the feasibility of a modified CHIVA strat- egy by means of endovenous lasers (EL) shrinkage of segmental great saphenous vein (GSV) tracts, in networks characterized by sapheno-femoral incompetence and re-entry perforators focused on the GSV. We report the follow up of the first 2 chronic venous disease [C1,2,3sEpAsPr1,2,3, venous clinical severity score (VCSS) 8 and 9 respectively] treated cases. At 1-year follow up both patients were C1,2,3sEpAsPr1,2,3 and the VCSS were 1 and 2 respectively. The non-treated GSV tracts main- tained their patency. ELs were herein used within a saphenous-sparing therapeutic plan, thanks to an accurate pre-operative hemody- namic assessment, which allowed the shrink- age of only the first saphenous trunk tract only. Proper technical and hemodynamic considera- tions are discussed. Introduction In the last decade, endovenous laser abla- tion (EVLA) has progressively dominated the chronic venous disease (CVD) therapeutic field.1 Nevertheless, strategically, EVLA hasn’t brought any innovations, since its first description by Navarro in 2001:2 the reflux abo- lition is obtained by the vein anatomical abla- tion, exactly like in surgical stripping. Conversely, hemodynamic correction (CHIVA) constitutes an alternative strategic approach for CVD treatment: a saphenous- sparing draining restoration that is character- ized by a scientifically validated efficacy.3-5 In order to combine the endovenous laser (EL) main technical strengths with the CHIVA strategy efficacy, an innovative therapeutic approach was used. After an accurate pre-operative hemody- namic assessment, the great saphenous vein (GSV) was shrunk distal to the superficial epi- gastric vein confluence (SEV), just for 7 to 10 centimeters. The remaining trunk was left draining reversely toward a previously selected re-entry perforator. We herein present the first 2 CVD cases that were already assessed at the one-year follow up. Case Reports Diagnostic assessment The first patient (case A) was a 47-year old male, with no co-morbidities, who was evaluat- ed for a C1,2,3sEpAsPr1,2,3 CVD, which was first diagnosed 4 years before. The clinical assessment assigned a venous clinical severity score (VCSS) of 8.6 The echo-color-Doppler investigation (ECD) identified a positive Valsalva and compres- sion/relaxation (C/R) maneuver at the femoral side of the terminal valve,7 an incompetent below-knee GSV tributary and an effective re- entry perforator on the mid-calf GSV trunk. According to CHIVA terminology, the patients presented a type I+N3 shunt (Figure 1).8,9 The second patient (case B) was a 64-year old male with arterial hypertension in the anamnestic record. He was evaluated for a C1,2,3sEpAsPr1,2,3 CVD, which was first diag- nosed 3 years before. The clinical assessment assigned a VCSS of 9.6 The ECD revealed a reflux pattern that was overlapping with the case A one (incompetent sapheno-femoral junction, re-entry perforator focused on the GSV, incompetent GSV tribu- tary, in this case located on the distal third of the leg, but however above the GSV re-entry perforator). Case A and B hemodynamic measures are reported in Table 1. Operative procedure On the same procedural day, both cases underwent an accurate pre-operative echo- guided mapping. Case A On the mid-calf, a flush disconnection of the incompetent GSV tributary was performed, leaving the saphenous breach opened in order to directly insert a 600 mm radial fiber of a 1470 nm 6W EL (Figure 2). Under ultrasound-guidance the fiber was then positioned just distal to the SEV. A tumescent anesthesia (lidocaine 2% 5 cc + sodium bicarbonate 5 cc + saline solution 10 cc) was administered perivenously by a 25 G needle, under ECD guidance, just along the 10 cm below the SEV, with a 40 cc total injection. The EL was then activated, shrinking the GSV at 100 J/cm and at 80 J/cm for the first 6 and the remaining 4 cm respectively. The total energy delivery recorded the fol- lowing parameters: i) laser on-time: 155 s; ii) total joules delivered: 928 J; iii) treated seg- ment length: 10 cm. After the fiber extraction, a 7/0 running suture was performed to close the saphenous breach. Case B A flush ligation of the incompetent GSV trib- utary was performed according to the CHIVA principles.8,9 Since the tributary was located on the distal third of the leg, percutaneous GSV access at the distal third of the thigh was preferred: with the patient in a reverse-Trendelemburg posi- tion, a 0.0035-in guide-wire was inserted through a 19 G needle into the GSV. The same case A device was then introduced (1470 nm, 6 W) and placed just below the SEV. The tumescent anesthesia was performed with the same compound, and injected perive- nously along the 7 cm below the SEV, for a total amount of 30 cc. Once the EL was activated, the GSV was shrunk at 100 J/cm and at 80 J/cm for the first 5 and the remaining 2 cm respectively. Correspondence: Sergio Gianesini, Vascular Disease Center, University of Ferrara, Via Aldo Moro 8, 44100 Ferrara, Italy. Tel. +39.0532.236524 - Fax: +39.0532.237144. E-mail: sergiogianesini@hotmail.com Key words: chronic venous disease, CHIVA, laser, conservative, hemodynamic Contributions: SG, study design, data acquisition, analysis and interpretation, manuscript drafting; EM, data acquisition, manuscript drafting; MZ, data acquisition; SA, SO, data analysis and inter- pretation; PZ, study design, data analysis and interpretation, manuscript revision. Conflict of interests: the authors declare no potential conflict of interests. Received for publication: 19 June 2013. Revision received: 7 September 2013. Accepted for publication: 9 September 2013. This work is licensed under a Creative Commons Attribution 3.0 License (by-nc 3.0). ©Copyright S. Gianesini et al., 2013 Licensee PAGEPress, Italy Veins and Lymphatics 2013; 2:e21 doi:10.4081/vl.2013.e21 No n- co mm er cia l u se on ly Case Report [Veins and Lymphatics 2013; 2:e21] [page 77] The total energy delivery recorded the fol- lowing parameters: i) laser on-time: 111 s; ii) total joules delivered: 671 J; iii) treated seg- ment length: 7 cm. In both cases, eccentric compression with cotton rolls on the treated veins was applied underneath a 20-30 mmHg thigh-length elastic stocking that was prescribed day and night for one week and only daily for the following week. The clinical and ECD follow-up was sched- uled at 1 week, then at 1-6-12 months. Results The patients referred no pain linked to the peri- and post-procedural time. Neither major nor minor complications were reported. Only a minor tightness feeling was reported in case B, during the first week, all along the 5 cm distally from the EL treated segment. A total relief was obtained after 3 days of non- steroidal anti-inflammatory drugs. Already at the 1 week ECD, case A showed a perfectly shrunk GSV tract from below the SEV to 10 cm downward. At 1 year follow up, in both patients, the clinical evaluation assessed a C1aEpAsPr1 class, while the case VCSS was 2 in case A and 1 in case B. Table 1 reports the 1 year follow up hemodynamic parameters which were assessed at the mid-thigh GSV portion in both cases (Figure 3). At the 1 week ECD, case B showed a perfect- ly shrunk GSV tract from below the SEV to 7 cm downward wall thickening, but also a wall thickening from the shrinkage distal end to other 8 cm downward (Figure 4). The tract affected by this wall thickening was compressible, vascularized and sponta- neously disappeared at the 1 month follow up. In both patients, the 1 year follow-up revealed a totally patent GSV from the shrunk tract downward (negative compression-ultra- sound maneuvers). At the compression/relax- ation maneuver the junctional tributaries showed a systolic centripetal flow, draining into the sapheno-femoral junction (Figure 2). Post-operatively the stump was 10.6 mm and 10.1 mm long in case A and B, respectively. Placing the PW (pulsed wave) sample on the femoral side of the terminal valve both Valsalva and C/R maneuvers were negative for reflux. No ballooning during strain was observed in both cases Pre-operatively the Giacomini vein was found to be competent in both cases. It was not identified post-operatively. Discussion The ever-increasing need for mini-invasive- ness, fast recovery and painless procedures have permitted EVLA to become one of the main therapeutic option in contemporary CVD management.1 Certainly, this technique has brought great technical advantages, but, at the same time, no improvements have been obtained in the strategic planning thus far: the procedure is based on the saphenous trunk ablation, exact- ly like in surgical stripping. The laser technique has brought great suc- cess in the quality of life improvement.10 Nevertheless, the long term clinical and ultra- sonographic results of this procedure haven’t being correspondingly satisfactory.11 The maintaining of an ablative strategy could be an explanation of the observed phenomenon and the herein presented strategy could offer an alternative model of venous hemodynamic investigation. On the contrary, the strategic Table 1. Morphologic and hemodynamic measurements recorded pre-operative and 1 year follow-up outcome both in case A and B. Case A Case B Pre-op Post-op Pre-op Post-op GSV diameter below the SEV(mm) 8.4 Totally shrunk 8.7 Totally shrunk GSV diameter at mid thigh (mm) 8.7 3.9 8.9 3.4 Reflux time (s) 2.3 Down-word draining flow 2.6 Down-word draining flow Peak systolic velocity (cm/s) 41.7 37.4 55.6 26.5 End diastolic velocity (cm/s) −11.5 10.1 −11.7 4.3 Resistance index 1.27 0.73 1.21 0.83 GSV, great saphenous vein; SEV, superficial epigastric vein. Figure 1. Femoral vein (FV), re-entry perforating vein (RP), and great saphenous vein (GSV). A) Physiological drainage: from the most superficial compartment to the deepest one, from the lowest to the upper part of the leg. B) Type I +N3 shunt: pathological inver- sion of the physiological order of emptying from N1 compartment to N2, adding an incompetent GSV tributary (N3). A re-entry perforator is focused on the GSV (N2). This allows the sapheno-femoral junction treatment. C) Type II shunt: Pathological inversion of the physiological order of emptying from N2 compartment to N3, with no compart- ment jump from N1 to N2. The incompetent tributary has its own RP directly draining into the N1 compartment, so that no closed circuits are formed. D) Type 3 shunt: patho- logical inversion of the physiological order of emptying from N1 compartment to N2, adding an incompetent GSV tributary (N3). No re-entry perforator is focused on the GSV. This forbids the sapheno-femoral junction treatment: in case of a sapheno-femoral junction disconnection/occlusion together with the incompetent tributary treatment would impede the draining into the GSV trunk so leading to thrombosis. No n- co mm er cia l u se on ly Case Report [page 78] [Veins and Lymphatics 2013; 2:e21] change that has been brought about by a saphenous-sparing surgical technique like CHIVA point towards better long term out- comes in CVD management,4 with a halved recurrence risk if compared to traditional stripping.3 Interestingly, the sapheno-femoral refluxing point suppression by EL confirmed the cre- ation of a not refluxing but rather reversed flow, draining the GSV trunk toward a re-entry perforator.12 Conversely, a strict application of the CHIVA principles would require the maintenance of the junctional tributaries draining into the GSV trunk.8,9 Certainly, the proposed segmental GSV shrinkage is feasible only in case of a re-entry perforator focused on the GSV trunk (30-40% of the CVD hemodynamic patterns).8,9 Therefore, from this perspective, our herein proposed therapeutic option can’t be dogmati- cally defined as a CHIVA procedure, but rather as an endovenous laser therapy to be per- formed according to CHIVA hemodynamic principles. The newly corrected flow pattern could pro- vide a study model in the sapheno-femoral junction tributaries hemodynamic investiga- tions, to be added to the ones that have been provided by past EVLA experiences. More specifically, it would be possible to implement the data concerning the recurrence rates in case of junctional tributaries ablation versus conservation.13 In our Center, the idea of combining the EL technique with the CHIVA strategy was con- ceived in order to melt together EVLA mini- invasiveness with the hemodynamic correc- tion long term efficacy. We can postulate that a less aggressive sapheno-femoral confluence treatment could reduce the recurrence risk.14 The successful outcome of the first 2 cases paves the way for an even greater diffusion of the laser technology, together with all the other minimally invasive techniques that are able to produce a subinguinal GSV occlusion (laser, radiofrequency, steam, glue mechanical). This new technologies innovative application could increase the interest toward hemodynamic saphenous-sparing strategies also in the non- surgical physicians.15 Of course, this therapeutic option elimi- nates the requirements for surgical skill of tra- ditional hemodynamic correction, but at the same time it forces all the involved physicians to possess an advanced sonographic knowl- edge. Future randomized comparative trials among the proposed strategy, pure CHIVA and traditional EVLA could provide answers to the following questions: - What is the hemodynamic role of the aspi- rating re-entry perforator in comparison to the GSV tributaries along the trunk in the draining maintenance? - What is the minimum shrinkage length for a long-lasting sapheno-femoral occlusion? - What is the most appropriate energy deliv- ery setting? - What are the hemodynamic parameters indicating a possible hemodynamic correc- tion by EL? - What are the hemodynamic features of the sapheno-femoral confluence to be assessed before an endovenous CHIVA planning? Conclusions Use of saphenous-sparing EL use seems to constitute an innovative and effective CVD therapeutic option. At the same time, it increases the potential efficacy of the not-sur- gical medical operators, and it forces all the involved physician into a deeper knowledge of the venous hemodynamics. Figure 2. Type 1 + 2 shunt. Femoral vein (N1), great saphenous vein (N2), great saphe- nous vein (GSV) tributary (N3), and re-entry perforator (RP). In type 1 shunt there is a reflux constituting a pathological subversion of the physiological order of venous emp- tying (from the surface to the deepest compartment of the lower limb). The compartment jump (from N1 to N2) is fed by an incompetent sapheno-femoral junction. An addition- al compartment jump can be observed from N2 to N3 because of an incompetent tribu- tary. A RP focused on the N2 compartment bring the shunted blood back to the N1 com- partment. Pure hemodynamic correction (CHIVA) 1 strategy indicates the suppression of the pathological N1-N2 compartment jump thanks to a high tie with junctional col- lateral preservation. Segmental GSV shrinkage by endovenous laser ablation (EVLA) offers a N1-N2 jump suppression, but leaving a sapheno-femoral junction stump, where the junctional tributaries can drain. Figure 3. Case A outcome at 12 months follow up. The superficial epigastric vein (SEV) is draining into the sapheno-femoral junction (SFJ), while the great saphenous (GSV) trunk remained shrunk. CFV, femoral vein. Figure 4. Case B wall thickening at the 1 week follow up echo-color-Doppler. The finding was extended from the distal great saphenous vein shrinkage for 8 cm down- ward. No n- co mm er cia l u se on ly Case Report [Veins and Lymphatics 2013; 2:e21] [page 79] Conclusive note The resistance index (ore resistive index or Pourcelo index) is a hemodynamic parameter reflecting the resistance to blood flow. It is also related to the vascular compliance and is obtained by the following formula: [(Peak systolic velocity - end diastolic veloc- ity)/Peak systolic velocity, RI] Practically, this represents a Doppler method to extrapolate an impedance parame- ter, expressing with a number the bi-direction- al flow and energy dissipation of the reflux phenomenon. References 1. Sadek M, Kabnick LS, Berland T, et al. Update on endovenous laser ablation. Perspect Vasc Endovasc Ther 2011;23:233- 7. 2. Navarro L, Min RJ, Boné C. Endovenous laser: a new minimally invasive method of treatment for varicose veins--preliminary observations using an 810 nm diode laser. Dermatol Surg. 2001;27:117-22. 3. Carandina S, Mari C, De Palma M, et al. Varicose vein stripping vs hemodynamic correction (CHIVA): a long term randomi- sed trial. Eur J Vasc Endovasc Surg 2008;35:230-7. 4. Pares JO, Juan J, Tellez R, et al. Varicose vein surgery: stripping versus the CHIVA method: a randomized controlled trial. Ann Surg 2010;251:624-31. 5. Zamboni P, Cisno C, Marchetti F, et al. Minimally invasive surgical mangement of primary venous ulcers vs. compression treatment: a randomized clinical trial. Eur J Vasc Endovasc Surg 2003;25:313-8. 6. Rutherford RB, Padberg FT Jr, Comerota AJ, et al. Venous severity scoring: An adjunct to venous outcome assessment. J Vasc Surg 2000;31:1307-12. 7. Cappelli M, Molino Lova R, Ermini S, Zamboni P. Hemodynamics of the saphe- no-femoral junction. Patterns of reflux and their clinical implications. Int Ang 2004; 23:25-8. 8. Franceschi C. Theorie et pratique de la cure conservatrice et hemodynamique de l’insuffisance veinuse en ambulatoire. Précy-sous-Thil: Ed. de L’Armancon; 1988. 9. Franceschi C, Zamboni P. Venous hemody- namics. Hauppauge, NY: Nova Science Publ.; 2009. 10. Darwood RJ, Theivacumar N, Dellagram - maticas D, et al. Randomized clinical trial comparing endovenous laser ablation with surgery for the treatment of primary great saphenous varicose veins. Br J Surg 2008; 95:294-301. 11. Murad MH, Yglesias FC, Garcia MZ, et al. A systemic review and meta-analysis of the treatments of varicose veins. J Vasc Surg 2011;53:49S-65S. 12. Tacconi G, Menegatti E, Fortini P, et al. Impedance and duplex haemodynamic parameters modifications induced by hae- modynamic correction type 1 (CHIVA 1). Oral Presentation. 9th European Venous Forum, Barcellona, Spain, June 26, 2008. Abstract 2.1. Available from: http://www. europeanvenousforum.org/evf2008/Book% 20of%20Abstracts.pdf 13. Disselhoff BC, der Kinderen DJ, Kelder JC, Moll FL. Randomized clinical trial compa- ring endovenous laser ablation of the great Saphenous vein with and without ligation of the sapheno-femoral junction: 2-year results. Eur J Vasc Endovasc Surg 2008;36: 713-8. 14. Van Rij AM, Jones GT, Hill GB, Jiang P. Neovascualrization and recurrent varicose veins:more histologic and ultrasound evi- dence. J Vasc Surg 2004;40:296-302. 15. Passariello F. Office Based CHIVA (OB Chiva). Acta Phlebol 2011;12:26-7. No n- co mm er cia l u se on ly